Cordis Corporation

genengnews.com: Genetic Engineering genengnews.com

Advaxis Taps Former ''Big Pharma'' FDA Specialist

genengnews.com     Apr 29, 2008   2 related          

News source: Business Wire Advaxis Inc., (OTCBB: ADXS, http://www.advaxis.com.), a developmental biotechnology company, has hired Christine Chansky, MD, JD, FCLM, a veteran clinician, pharmaceutical industry Medical Director, and Food & Drug Administration ("FDA")...                    

comments

Shopping for a Check-Up? PDQ Care Opens Nation's First Walk-in Clinic and Pharmacy in a Mall

redorbit.com     Apr 28, 2008          

PDQ Care, Inc., www.pdqcare.com, has introduced what is believed to be the nation's first combination Walk-In Clinic and Pharmacy at a regional shopping mall with the recent opening at The Mall at Wellington Green. ... As one of the fastest growing trends in the nation's...                    

comments

J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc.

prnewswire.com     Apr 28, 2008   3 related          

RESEARCH TRIANGLE PARK, N.C., April 28 /PRNewswire/ -- Tryton Medical, Inc. announced today that it has appointed J. Greg Davis as President and Chief Executive Officer. "Tryton's elegant design, ease-of-use and stellar clinical results are impressive. "We believe his...                    

comments

Cardiovascular Catheters and Systems Market to reach 34 billion by 2010 According to New Report...

prnewsnow.com     Apr 16, 2008   7 related          

(Cardiology News and Information) The worldwide cardiovascular catheters and systems market rides on a wave of technological advancements associated with catheters which ensure improved maneuverability and insertion capabilities Rapid advancements in technology have resulted in the production of...                    

comments

                   

NEJM Study Demonstrates Carotid Stenting with Embolic Protection is Comparable to Surgery

webwire.com     Apr 15, 2008          

SAPPHIRE Three-Year Study Demonstrates Equivalent Stroke and Repeat Procedure Outcomes - - Warren, NJ.— According to a study published in The New England Journal of Medicine this week, three-year data ... [WebWire - Tuesday, April 15, 2008] ... stroke, heart attack,...                    

comments

                   

NEJM Study Demonstrates Carotid Stenting With Embolic Protection Is Comparable To Surgery

medicalnewstoday.com     Apr 11, 2008   4 related          

According to a study published in The New England Journal of Medicine this week, three-year data from the Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy (SAPPHIRE) study in patients with severe blocked carotid arteries, the main blood vessels in the neck leading                    

comments

NEJM study demonstrates carotid stenting with embolic protection is comparable to surgery

eurekalert.org     Apr 9, 2008   18 related          

According to a study published in NEJM, three-year data from the SAPPHIRE study in patients with severe blocked carotid arteries, the main blood vessels in the neck leading to the brain, who underwent carotid artery stenting with the PRECISE Nitinol Stent and the ANGIOGUARD Emboli Capture...                    

comments

Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe (PR...

yahoo.com     Apr 7, 2008   3 related          

Stereotaxis, Inc. , announced today that it has made two strategic additions to its senior management team. ... Monday April 7, 6:30 am ET Former C.R. Bard and Biosense Webster Executives Join Stereotaxis ST. LOUIS, April 7, 2008 /PRNewswire-FirstCall/ -- The Company...                    

comments

Three Year Follow-Up Data Suggest Better Outcomes Were Maintained with the Cypher®...

webwire.com     Apr 2, 2008   9 related          

Chicago, IL . — Long-term, follow-up data presented today suggest that patients who received the CYPHER® Sirolimus-eluting Coronary Stent for blockage of a bare metal stent were significantly less lik... [WebWire - Wednesday, April 02, 2008] ... WEBWIRE – Wednesday, April...                    

comments

CYPHER® Stent - The Most Studied, The Most Used, The Most Proven

bibsonomy.org     Apr 1, 2008          

Cypher is a drug-eluting coronary (heart) stent used in during angioplasty procedures. ... Get the latest information about new studies relating to the performance of the CYPHER® Stent. The CYPHER® Stent is not for everyone — especially those who cannot take antiplatelet...                    

comments